Prelude Therapeutics
PRLD
#9213
Rank
โ‚น5.80 B
Marketcap
โ‚น105.56
Share price
-4.62%
Change (1 day)
-69.64%
Change (1 year)

Prelude Therapeutics (PRLD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น3.47 Billion

According to Prelude Therapeutics's latest financial reports the company's total liabilities are โ‚น3.47 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Prelude Therapeutics - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น3.37 B62.87%
2022-12-31โ‚น2.07 B45.12%
2021-12-31โ‚น1.42 B71.31%
2020-12-31โ‚น0.83 B-83.59%
2019-12-31โ‚น5.08 B85.93%
2018-12-31โ‚น2.73 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.39 B-31.17%๐Ÿ‡บ๐Ÿ‡ธ USA